Tyrosinemia type 3

Search Trials
Biomarker for the Early Diagnosis and Monitoring in Tyrosinemia Type 1 (BioTyrosin)
Status:
Active, not recruiting
Last Changed:
May 18, 2021
First Changed:
Sep 15, 2017
Disease(s):
Tyrosinosis
Long Term Safety Study of Orfadin Treatment in HT-1 Patients in Standard Clinical Care
Status:
Completed
Last Changed:
Jan 14, 2020
First Changed:
Dec 19, 2014
Disease(s):
Hereditary Tyrosinemia, Type I
Intervention(s):
Nitisinone
Bioequivalence Study of Two Oral Nitisinone Formulations to Treat Hereditary Tyrosinemia (HT-1)
Status:
Completed
Last Changed:
Jun 14, 2017
First Changed:
Apr 25, 2016
Disease(s):
Hereditary Tyrosinemia, Type I
Intervention(s):
NitisinoneNitisinone Baked TabletOrfadin
Bioavailability Food-Effect Study of an Oral Nitisinone Formulation to Treat Hereditary Tyrosinemia (HT-1)
Status:
Completed
Last Changed:
Mar 15, 2017
First Changed:
Apr 25, 2016
Disease(s):
Hereditary Tyrosinemia, Type I
Intervention(s):
Nitisinone
Hereditary Hepatorenal Tyrosinemia Natural History in Egypt and the Arab World (Multicenter Clinical Study)
Status:
Recruiting
Last Changed:
Jan 10, 2019
First Changed:
Feb 27, 2018
Disease(s):
Hereditary Tyrosinemia, Type I

Connect. Empower. Inspire.